Episode Details

Back to Episodes
Wegovy’s So-Called “Long-Term” Study

Wegovy’s So-Called “Long-Term” Study

Published 3 years, 1 month ago
Description

Today we are breaking down Novo Nordisk's 2-year study of their weight loss drug, Wegovy. I want to thank Deb Burgard for her help with this piece. She is quoted and was kind enough to review and give feedback on the piece and I am incredibly grateful!



Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us